Old Web
English
Sign In
Acemap
>
authorDetail
>
Vishal Boolell
Vishal Boolell
Medicine
in patient
Pathology
Oncology
Internal medicine
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 study of CRLX301, a novel nanoparticle-drug conjugate (NDC) containing docetaxel (DOC), in patients with refractory solid tumors.
2016
Journal of Clinical Oncology
Ben Markman
Paul de Souza
Elizabeth Claire Dees
Tara C. Gangadhar
Adam Cooper
Aflah Roohullah
Vishal Boolell
William C. Zamboni
Curran Murphy
Adrian M. Senderowicz
H. Wang
Show All
Source
Cite
Save
Citations (11)
A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors.
2016
Journal of Clinical Oncology
Jayesh Desai
Ben Markman
Shahneen Sandhu
Hui K. Gan
Michael Friedlander
Ben Tran
Tarek M. Meniawy
Vishal Boolell
Duncan Colyer
Christie Norris
Malaka Ameratunga
Jason Yang
Kang Li
Lai Wang
Lusong Luo
Zhen Qin
Michael Millward
Show All
Source
Cite
Save
Citations (5)
Impact of primary tumor stage on survival following resection of metachronous liver and/or lung metastases in colorectal cancer.
2015
Journal of Clinical Oncology
Hui-Li Wong
Vishal Boolell
Suzanne Kosmider
Kathryn Maree Field
Rachel Wong
Jeremy David Shapiro
Prasad Cooray
Ian P. Hayes
Ian Faragher
Malcolm Steel
Peter Gibbs
Show All
Source
Cite
Save
Citations (1)
1